{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:36:01Z","timestamp":1787016961354,"version":"build-2736575974"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PON 2014-2021 \u201cResearch and Innovation\" resources - Green - DM MUR 1062\/2021"],"award-info":[{"award-number":["PON 2014-2021 \u201cResearch and Innovation\" resources - Green - DM MUR 1062\/2021"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PNRR ECS00000017 \u201cTHE - Tuscany Health Ecosystem\u201d - Spoke 6 \u201cPrecision medicine & personalized healthcare\u201d, funded by the European Commission under the NextGenerationEU programme"],"award-info":[{"award-number":["PNRR ECS00000017 \u201cTHE - Tuscany Health Ecosystem\u201d - Spoke 6 \u201cPrecision medicine & personalized healthcare\u201d, funded by the European Commission under the NextGenerationEU programme"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PON 2014-2021 \u201cResearch and Innovation\" resources - Green - DM MUR 1062\/2021"],"award-info":[{"award-number":["PON 2014-2021 \u201cResearch and Innovation\" resources - Green - DM MUR 1062\/2021"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["POS 2014-2020, project ID: T4-AN-07, CUP: I53C22001300001"],"award-info":[{"award-number":["POS 2014-2020, project ID: T4-AN-07, CUP: I53C22001300001"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-56079-3","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T19:52:36Z","timestamp":1780775556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systems biology-based drug repurposing for neuroinflammation treatment in activated human microglia"],"prefix":"10.1038","volume":"16","author":[{"given":"Martina","family":"Cirinciani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Germelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Da Pozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Priami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Milazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"56079_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/jnc.13607","volume":"139","author":"DJ DiSabato","year":"2016","unstructured":"DiSabato, D. J., Quan, N. & Godbout, J. P. Neuroinflammation: the devil is in the details. J. Neurochem. 139, 136\u2013153 (2016).","journal-title":"J. Neurochem"},{"key":"56079_CR2","doi-asserted-by":"publisher","unstructured":"Lyman, M. et al. The role and consequences. Neuroscience Research vol. 79 1\u201312 Preprint at (2014). https:\/\/doi.org\/10.1016\/j.neures.2013.10.004","DOI":"10.1016\/j.neures.2013.10.004"},{"key":"56079_CR3","doi-asserted-by":"publisher","unstructured":"Leng, F. & Edison, P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nature Reviews Neurology vol. 17 157\u2013172 Preprint at (2021). https:\/\/doi.org\/10.1038\/s41582-020-00435-y","DOI":"10.1038\/s41582-020-00435-y"},{"key":"56079_CR4","doi-asserted-by":"crossref","unstructured":"Heinz, R. et al. Microglia as target for anti-inflammatory approaches to prevent secondary brain injury after subarachnoid hemorrhage (SAH). J Neuroinflammation 18, (2021).","DOI":"10.1186\/s12974-021-02085-3"},{"key":"56079_CR5","first-page":"3559","volume":"22","author":"JL Zhao","year":"2020","unstructured":"Zhao, J. L. et al. Expression of TNF-\u03b1 and IL-\u03b2 can be suppressed via the PPAR-\u03b3\/mTOR signaling pathway in BV-2 microglia: A potential anti-inflammation mechanism. Mol. Med. Rep. 22, 3559\u20133565 (2020).","journal-title":"Mol. Med. Rep."},{"key":"56079_CR6","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/mp.2016.46","volume":"21","author":"ML Wong","year":"2016","unstructured":"Wong, M. L. et al. Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition. Mol. Psychiatry. 21, 797\u2013805 (2016).","journal-title":"Mol. Psychiatry"},{"key":"56079_CR7","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00401-021-02293-4","volume":"141","author":"L van Olst","year":"2021","unstructured":"van Olst, L. et al. Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration. Acta Neuropathol. 141, 881\u2013899 (2021).","journal-title":"Acta Neuropathol."},{"key":"56079_CR8","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1002\/alz.12341","volume":"17","author":"AB Lopez-Rodriguez","year":"2021","unstructured":"Lopez-Rodriguez, A. B. et al. Acute systemic inflammation exacerbates neuroinflammation in Alzheimer\u2019s disease: IL-1\u03b2 drives amplified responses in primed astrocytes and neuronal network dysfunction. Alzheimer\u2019s Dement. 17, 1735\u20131755 (2021).","journal-title":"Alzheimer\u2019s Dement."},{"key":"56079_CR9","first-page":"22538","volume":"22","author":"X Lushuang","year":"2020","unstructured":"Lushuang, X. et al. Inflammatory factors and amyloid \u03b2-induced microglial polarization promote inflammatory crosstalk with astrocytes. Aging 22, 22538\u201322549 (2020).","journal-title":"Aging"},{"key":"56079_CR10","doi-asserted-by":"crossref","unstructured":"Misselbeck, K. et al. A network-based approach to identify deregulated pathways and drug effects in metabolic syndrome. Nat Commun 10, (2019).","DOI":"10.1038\/s41467-019-13208-z"},{"key":"56079_CR11","doi-asserted-by":"publisher","unstructured":"Jarada, T. N., Rokne, J. G. & Alhajj, R. A review of computational drug repositioning: Strategies, approaches, opportunities, challenges, and directions. Journal of Cheminformatics vol. 12 Preprint at (2020). https:\/\/doi.org\/10.1186\/s13321-020-00450-7","DOI":"10.1186\/s13321-020-00450-7"},{"key":"56079_CR12","doi-asserted-by":"publisher","first-page":"100042","DOI":"10.1016\/j.crchbi.2023.100042","volume":"3","author":"L Cai","year":"2023","unstructured":"Cai, L. et al. Machine learning for drug repositioning: Recent advances and challenges. Curr. Res. Chem. Biology. 3, 100042 (2023).","journal-title":"Curr. Res. Chem. Biology"},{"key":"56079_CR13","doi-asserted-by":"crossref","unstructured":"Rodriguez, S. et al. Machine learning identifies candidates for drug repurposing in Alzheimer\u2019s disease. Nat Commun 12, (2021).","DOI":"10.1038\/s41467-021-21330-0"},{"key":"56079_CR14","doi-asserted-by":"crossref","unstructured":"Cheng, F. et al. Network-based approach to prediction and population-based validation of in silico drug repurposing. Nat Commun 9, (2018).","DOI":"10.1038\/s41467-018-05116-5"},{"key":"56079_CR15","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1093\/bioinformatics\/bty133","volume":"34","author":"A Peyvandipour","year":"2018","unstructured":"Peyvandipour, A., Saberian, N., Shafi, A., Donato, M. & Draghici, S. Systems biology: A novel computational approach for drug repurposing using systems biology. Bioinformatics 34, 2817\u20132825 (2018).","journal-title":"Bioinformatics"},{"key":"56079_CR16","doi-asserted-by":"publisher","unstructured":"Arrell, D. K. & Terzic, A. Network systems biology for drug discovery. Clinical Pharmacology and Therapeutics vol. 88 120\u2013125 Preprint at (2010). https:\/\/doi.org\/10.1038\/clpt.2010.91","DOI":"10.1038\/clpt.2010.91"},{"key":"56079_CR17","doi-asserted-by":"crossref","unstructured":"Sadegh, S. et al. Network medicine for disease module identification and drug repurposing with the NeDRex platform. Nat Commun 12, (2021).","DOI":"10.1038\/s41467-021-27138-2"},{"key":"56079_CR18","doi-asserted-by":"crossref","unstructured":"Xu, P. et al. Microglial TREM-1 receptor mediates neuroinflammatory injury via interaction with SYK in experimental ischemic stroke. Cell Death Dis 10, (2019).","DOI":"10.1038\/s41419-019-1777-9"},{"key":"56079_CR19","doi-asserted-by":"crossref","unstructured":"Fan, Z., Su, D., Li, Z. C., Sun, S. & Ge, Z. Metformin attenuates central sensitization by regulating neuroinflammation through the TREM2-SYK signaling pathway in a mouse model of chronic migraine. Journal Neuroinflammation 21, (2024).","DOI":"10.1186\/s12974-024-03313-2"},{"key":"56079_CR20","doi-asserted-by":"crossref","unstructured":"Liu, X., Xu, B. & Gao, S. Spleen tyrosine kinase mediates microglial activation in mice with diabetic retinopathy. Transl Vis. Sci. Technol 10, (2021).","DOI":"10.1167\/tvst.10.4.20"},{"key":"56079_CR21","doi-asserted-by":"crossref","unstructured":"Zhang, W. et al. CD22 blockade exacerbates neuroinflammation in Neuromyelitis optica spectrum disorder. Journal Neuroinflammation 21, (2024).","DOI":"10.1186\/s12974-024-03305-2"},{"key":"56079_CR22","doi-asserted-by":"crossref","unstructured":"McQuade, A. et al. Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u2019s disease. Nat Commun 11, (2020).","DOI":"10.1038\/s41467-020-19227-5"},{"key":"56079_CR23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.drudis.2010.05.001","volume":"15","author":"M Riccaboni","year":"2010","unstructured":"Riccaboni, M., Bianchi, I. & Petrillo, P. Spleen tyrosine kinases: Biology, therapeutic targets and drugs. Drug Discovery Today. 15, 517\u2013530 (2010). https:\/\/doi.org\/10.1016\/j.drudis.2010.05.001 Preprint at.","journal-title":"Drug Discovery Today"},{"key":"56079_CR24","doi-asserted-by":"crossref","unstructured":"Stelzer, G. et al. The GeneCards suite: From gene data mining to disease genome sequence analyses. Curr. Protoc. Bioinformatics 1.30.1\u20131.30.33 (2016). (2016).","DOI":"10.1002\/cpbi.5"},{"key":"56079_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"key":"56079_CR26","doi-asserted-by":"publisher","first-page":"D408","DOI":"10.1093\/nar\/gkw985","volume":"45","author":"G Alanis-Lobato","year":"2017","unstructured":"Alanis-Lobato, G., Andrade-Navarro, M. A. & Schaefer, M. H. HIPPIE v2.0: Enhancing meaningfulness and reliability of protein-protein interaction networks. Nucleic Acids Res. 45, D408\u2013D414 (2017).","journal-title":"Nucleic Acids Res."},{"key":"56079_CR27","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart, D. S. et al. DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Res. 46, D1074\u2013D1082 (2018).","journal-title":"Nucleic Acids Res."},{"key":"56079_CR28","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","volume":"171","author":"A Subramanian","year":"2017","unstructured":"Subramanian, A. et al. A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles. Cell 171, 1437\u20131452e17 (2017).","journal-title":"Cell"},{"key":"56079_CR29","unstructured":"Lamb, J. et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease. (2006). www.broad.mit.edu\/cmap"},{"key":"56079_CR30","doi-asserted-by":"crossref","unstructured":"Zhou, Y. et al. Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2. Cell Discov 6, (2020).","DOI":"10.1038\/s41421-020-0153-3"},{"key":"56079_CR31","doi-asserted-by":"publisher","first-page":"D1302","DOI":"10.1093\/nar\/gkaa1027","volume":"49","author":"D Ochoa","year":"2021","unstructured":"Ochoa, D. et al. Open Targets Platform: Supporting systematic drug-target identification and prioritisation. Nucleic Acids Res. 49, D1302\u2013D1310 (2021).","journal-title":"Nucleic Acids Res."},{"key":"56079_CR32","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/ajh.25125","volume":"93","author":"J Bussel","year":"2018","unstructured":"Bussel, J. et al. Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials. Am. J. Hematol. 93, 921\u2013930 (2018).","journal-title":"Am. J. Hematol."},{"key":"56079_CR33","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00296-016-3482-7","volume":"36","author":"S Kunwar","year":"2016","unstructured":"Kunwar, S., Devkota, A. R. & Ghimire, D. K. C. Fostamatinib, an oral spleen tyrosine kinase inhibitor, in the treatment of rheumatoid arthritis: a meta-analysis of randomized controlled trials. Rheumatol. Int. 36, 1077\u20131087 (2016).","journal-title":"Rheumatol. Int."},{"key":"56079_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/path.4598","volume":"238","author":"J Ryan","year":"2016","unstructured":"Ryan, J. et al. Myeloid cell-mediated renal injury in rapidly progressive glomerulonephritis depends upon spleen tyrosine kinase. J. Pathol. 238, 10\u201320 (2016).","journal-title":"J. Pathol."},{"key":"56079_CR35","doi-asserted-by":"crossref","unstructured":"Sun, S. et al. R406 elicits anti-Warburg effect via Syk-dependent and -independent mechanisms to trigger apoptosis in glioma stem cells. Cell Death Dis 10, (2019).","DOI":"10.1038\/s41419-019-1587-0"},{"key":"56079_CR36","doi-asserted-by":"crossref","unstructured":"Tullemans, B. M. E. et al. Multiparameter evaluation of the platelet-inhibitory effects of tyrosine kinase inhibitors used for cancer treatment. Int J. Mol. Sci 22, (2021).","DOI":"10.3390\/ijms222011199"},{"key":"56079_CR37","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/infdis\/jiaa789","volume":"223","author":"JR Strich","year":"2021","unstructured":"Strich, J. R. et al. Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic. J. Infect. Dis. 223, 981\u2013984 (2021).","journal-title":"J. Infect. Dis."},{"key":"56079_CR38","unstructured":"Wayne Meikle, A., Tyler, F. H. & Lake City, S. Potency and Duration of Action of Glucocorticoids Effects of Hydrocortisone, Prednisone and Dexamethasone on Human Pituitary-Adrenal Function. (1977)."},{"key":"56079_CR39","doi-asserted-by":"crossref","unstructured":"Da Pozzo, E. et al. Microglial pro-inflammatory and anti-inflammatory phenotypes are modulated by translocator protein activation. Int J. Mol. Sci 20, (2019).","DOI":"10.3390\/ijms20184467"},{"key":"56079_CR40","doi-asserted-by":"crossref","unstructured":"Verre, J., Boisson, M., Paumier, A., Tribolo, S. & Boujedaini, N. Anti-inflammatory effects of Arnica montana (mother tincture and homeopathic dilutions) in various cell models. J Ethnopharmacol 318, (2024).","DOI":"10.1016\/j.jep.2023.117064"},{"key":"56079_CR41","doi-asserted-by":"publisher","unstructured":"Dello Russo, C. et al. The human microglial HMC3 cell line: Where do we stand? A systematic literature review. Journal of Neuroinflammation vol. 15 Preprint at (2018). https:\/\/doi.org\/10.1186\/s12974-018-1288-0","DOI":"10.1186\/s12974-018-1288-0"},{"key":"56079_CR42","doi-asserted-by":"publisher","unstructured":"Jang, D. I. et al. The role of tumor necrosis factor alpha (Tnf-\u03b1) in autoimmune disease and current tnf-\u03b1 inhibitors in therapeutics. International Journal of Molecular Sciences vol. 22 1\u201316 Preprint at (2021). https:\/\/doi.org\/10.3390\/ijms22052719","DOI":"10.3390\/ijms22052719"},{"key":"56079_CR43","doi-asserted-by":"publisher","unstructured":"Swanson, K. V., Deng, M. & Ting, J. P. Y. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nature Reviews Immunology vol. 19 477\u2013489 Preprint at (2019). https:\/\/doi.org\/10.1038\/s41577-019-0165-0","DOI":"10.1038\/s41577-019-0165-0"},{"key":"56079_CR44","doi-asserted-by":"publisher","unstructured":"Spittau, B., Dokalis, N. & Prinz, M. The Role of TGF\u03b2 Signaling in Microglia Maturation and Activation. Trends in Immunology vol. 41 836\u2013848 Preprint at (2020). https:\/\/doi.org\/10.1016\/j.it.2020.07.003","DOI":"10.1016\/j.it.2020.07.003"},{"key":"56079_CR45","doi-asserted-by":"publisher","unstructured":"Khawaja, F. R., Zhang, Z., Memon, Y. & Ullah, A. Exploring community detection methods and their diverse applications in complex networks: a comprehensive review. Social Network Analysis and Mining vol. 14 Preprint at (2024). https:\/\/doi.org\/10.1007\/s13278-024-01274-1","DOI":"10.1007\/s13278-024-01274-1"},{"key":"56079_CR46","doi-asserted-by":"crossref","unstructured":"Crowley, M. T. et al. A Critical Role for Syk in Signal Transduction and Phagocytosis Mediated by Fc Receptors on Macrophages. J Exp. Med vol. 186 (1997). http:\/\/www.jem.org","DOI":"10.1084\/jem.186.7.1027"},{"key":"56079_CR47","doi-asserted-by":"publisher","unstructured":"Yi, Y. S. et al. Functional roles of Syk in macrophage-mediated inflammatory responses. Mediators of Inflammation vol. Preprint at (2014). https:\/\/doi.org\/10.1155\/2014\/270302 (2014).","DOI":"10.1155\/2014\/270302"},{"key":"56079_CR48","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1124\/jpet.106.109058","volume":"319","author":"S Braselmann","year":"2006","unstructured":"Braselmann, S. et al. R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation. J. Pharmacol. Exp. Ther. 319, 998\u20131008 (2006).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"56079_CR49","doi-asserted-by":"crossref","unstructured":"Birkle, T. J. Y. & Brown, G. C. Syk inhibitors protect against microglia-mediated neuronal loss in culture. Front Aging Neurosci 15, (2023).","DOI":"10.3389\/fnagi.2023.1120952"},{"key":"56079_CR50","doi-asserted-by":"crossref","unstructured":"He, X. et al. BAY61-3606 attenuates neuroinflammation and neurofunctional damage by inhibiting microglial Mincle\/Syk signaling response after traumatic brain injury. Int J. Mol. Med 49, (2022).","DOI":"10.3892\/ijmm.2021.5060"},{"key":"56079_CR51","doi-asserted-by":"crossref","unstructured":"Kim, M. W. et al. Pharmacological Inhibition of Spleen Tyrosine Kinase Suppressed Neuroinflammation and Cognitive Dysfunction in LPS-Induced Neurodegeneration Model. Cells 11, (2022).","DOI":"10.3390\/cells11111777"},{"key":"56079_CR52","doi-asserted-by":"publisher","unstructured":"Cooper, N. et al. Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib. Platelets vol. 34 Preprint at (2023). https:\/\/doi.org\/10.1080\/09537104.2022.2131751","DOI":"10.1080\/09537104.2022.2131751"},{"key":"56079_CR53","unstructured":"European Medicines Agency. Tavlesse (Fostamatinib Disodium Hexahydrate) [Assessment Report]. www.ema.europa.eu\/contact"},{"key":"56079_CR54","doi-asserted-by":"crossref","unstructured":"Galan-Vasquez, E. & Perez-Rueda, E. A landscape for drug-target interactions based on network analysis. PLoS One 16, (2021).","DOI":"10.1371\/journal.pone.0247018"},{"key":"56079_CR55","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1002\/jnr.23082","volume":"90","author":"JE Tichauer","year":"2012","unstructured":"Tichauer, J. E. & von Bernhardi, R. Transforming growth factor-\u03b2 stimulates \u03b2 amyloid uptake by microglia through Smad3-dependent mechanisms. J. Neurosci. Res. 90, 1970\u20131980 (2012).","journal-title":"J. Neurosci. Res."},{"key":"56079_CR56","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/imm.13900","volume":"175","author":"B Gunasegaran","year":"2025","unstructured":"Gunasegaran, B. et al. Comparative Analysis of HMC3 and C20 Microglial Cell Lines Reveals Differential Myeloid Characteristics and Responses to Immune Stimuli. Immunology 175, 84\u2013102 (2025).","journal-title":"Immunology"},{"key":"56079_CR57","doi-asserted-by":"crossref","unstructured":"Rai, M. A. et al. Comparative analysis of human microglial models for studies of HIV replication and pathogenesis. Retrovirology 17, (2020).","DOI":"10.1186\/s12977-020-00544-y"},{"key":"56079_CR58","doi-asserted-by":"crossref","unstructured":"\u00c7etin, G. et al. Immunoproteasomes control activation of innate immune signaling and microglial function. Front Immunol 13, (2022).","DOI":"10.3389\/fimmu.2022.982786"},{"key":"56079_CR59","doi-asserted-by":"crossref","unstructured":"Baek, M. et al. The BET inhibitor attenuates the inflammatory response and cell migration in human microglial HMC3 cell line. Sci Rep 11, (2021).","DOI":"10.1038\/s41598-021-87828-1"},{"key":"56079_CR60","doi-asserted-by":"crossref","unstructured":"Davis, R. L., Buck, D. J., McCracken, K., Cox, G. W. & Das, S. Interleukin-1\u03b2-induced inflammatory signaling in C20 human microglial cells. Neuroimmunol. Neuroinflamm. (2018). (2018).","DOI":"10.20517\/2347-8659.2018.60"},{"key":"56079_CR61","doi-asserted-by":"publisher","unstructured":"Ivashkiv, L. B. & Donlin, L. T. Regulation of type i interferon responses. Nature Reviews Immunology vol. 14 36\u201349 Preprint at (2014). https:\/\/doi.org\/10.1038\/nri3581","DOI":"10.1038\/nri3581"},{"key":"56079_CR62","doi-asserted-by":"publisher","first-page":"e70061","DOI":"10.1111\/cns.70061","volume":"30","author":"H He","year":"2024","unstructured":"He, H. et al. Microglial priming by IFN-\u03b3 involves STAT1-mediated activation of the NLRP3 inflammasome. CNS Neurosci. Ther. 30, e70061 (2024).","journal-title":"CNS Neurosci. Ther."},{"key":"56079_CR63","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.imbio.2018.09.002","volume":"224","author":"G Wildner","year":"2019","unstructured":"Wildner, G. Are rats more human than mice? Immunobiology 224, 172\u2013176 (2019).","journal-title":"Immunobiology"},{"key":"56079_CR64","doi-asserted-by":"publisher","unstructured":"Matsukane, R., Suetsugu, K., Hirota, T. & Ieiri, I. Clinical Pharmacokinetics and Pharmacodynamics of Fostamatinib and Its Active Moiety R406. Clinical Pharmacokinetics vol. 61 955\u2013972 Preprint at (2022). https:\/\/doi.org\/10.1007\/s40262-022-01135-0","DOI":"10.1007\/s40262-022-01135-0"},{"key":"56079_CR65","doi-asserted-by":"crossref","unstructured":"Wei, C. H., Kao, H. Y. & Lu, Z. PubTator: a web-based text mining tool for assisting biocuration. Nucleic Acids Res 41, (2013).","DOI":"10.1093\/nar\/gkt441"},{"key":"56079_CR66","doi-asserted-by":"publisher","first-page":"5545","DOI":"10.1007\/s10787-025-01815-w","volume":"33","author":"AK Mishra","year":"2025","unstructured":"Mishra, A. K., Sahoo, P. K., Singh, R. & Jain, S. Tectoridin modulates intertwined molecular pathways in metabolic syndrome: insights from network pharmacology, molecular docking, and in vivo studies. Inflammopharmacology 33, 5545\u20135562 (2025).","journal-title":"Inflammopharmacology"},{"key":"56079_CR67","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/nprot.2009.97","volume":"4","author":"S Durinck","year":"2009","unstructured":"Durinck, S., Spellman, P. T., Birney, E. & Huber, W. Mapping identifiers for the integration of genomic datasets with the R\/ Bioconductor package biomaRt. Nat. Protoc. 4, 1184\u20131191 (2009).","journal-title":"Nat. Protoc."},{"key":"56079_CR68","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: A software Environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504 (2003).","journal-title":"Genome Res."},{"key":"56079_CR69","doi-asserted-by":"publisher","first-page":"D932","DOI":"10.1093\/nar\/gkw993","volume":"45","author":"O Ursu","year":"2017","unstructured":"Ursu, O. et al. DrugCentral: Online drug compendium. Nucleic Acids Res. 45, D932\u2013D939 (2017).","journal-title":"Nucleic Acids Res."},{"key":"56079_CR70","doi-asserted-by":"crossref","unstructured":"Alvarez-Carbonell, D. et al. Toll-like receptor 3 activation selectively reverses HIV latency in microglial cells. Retrovirology 14, (2017).","DOI":"10.1186\/s12977-017-0335-8"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56079-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56079-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56079-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:45:54Z","timestamp":1787013954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56079-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["56079"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-56079-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25871"}}